评估双边前庭病变:整合VHIT和DHI以获得临床见解和功能结果
Mehmet Surmeli1, Reyhan Surmeli2, Serap Sahin Onder1
1Department of Otolaryngology, University of Health Sciences, Umraniye Training and Research Hospital, Istanbul, Turkey.
Acta oto-laryngologica
|November 26, 2025
概括
耳毒性药物是双边前庭病变 (BVP) 的主要原因,特别是在患有并发症的老年人中. 整合客观 (vHIT) 和主观 (DHI) 评估对于评估 BVP 功能结果至关重要.
科学领域:
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 双边前庭膜病变 (BVP) 是一种罕见的疾病,由于前庭膜眼反射受损,严重影响生活质量.
- 耳毒性是BVP的一个显著,但经常被忽视的原因.
研究的目的:
- 调查导致BVP的病因因素.
- 用主观和客观措施评估BVP患者的功能结果.
主要方法:
- 对31名BVP患者的回顾性分析.
- 评估人口统计数据,病因和并发症.
- 使用头障碍清单 (DHI) 和视频头部脉冲测试 (vHIT) 评估功能结果.
主要成果:
- 主要来自aminoglycosides的耳毒性是BVP的主要原因 (41.9%).
- 老年和并发症被确定为耳毒性风险因素.
- 在vHIT增长和DHI得分之间发现了显著的负相关性,表明障碍较高的功能较差.
结论:
- 耳毒药物是BVP的主要原因,特别是在患有并发症的老年患者中.
- 结合vHIT和DHI的使用提供了对BVP的全面评估.
- 提高对耳毒性的认识以及客观和主观评估的互补使用对于管理BVP至关重要.
相关概念视频
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...


